Download PDF
Thromb Haemost 2010; 103(01): 1-2
DOI: 10.1055/s-0037-1608917
Editorial
Schattauer GmbH

Moving forward with a new Editorial team for Thrombosis and Haemostasis

Christian Weber
1   Insitute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
,
Gregory Y. H. Lip
2   Haemostasis Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
› Author Affiliations
Further Information

Publication History

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Weber C. Chemokines take centre stage in vascular biology. Thromb Haemost 2007; 97: 685-687.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Braun T, Preissner KT. Cutting edge research for novel therapies of heart and lung diseases. Thromb Haemost 2009; 101: 610-612.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Weber C. Frontiers in vascular biology: mechanisms of inflammation and immunoregulation in arterial remodelling. Thromb Haemost 2009; 102: 188-190.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Lip GYH, Huber K, Andreotti F. et al. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting With Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting: A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. Thromb Haemost 2010; 103: 13-28.
    Article in Thieme ConnectPubMedGoogle Scholar